Skip to main content
Clinical Trials/CTRI/2023/09/057510
CTRI/2023/09/057510
Completed
Phase 2

A Clinical Study on the Management of Benign ProstaticHyperplasia with a Unani Polyherbal Formulation An open label single Arm Trial - NI

Ayurvedic and Unani Tibbia College Hospital0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Sponsor
Ayurvedic and Unani Tibbia College Hospital
Enrollment
40
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 14, 2024
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Ayurvedic and Unani Tibbia College Hospital

Eligibility Criteria

Inclusion Criteria

  • Daignosed cases of Benign Prostatic Hyperplasia on digital rectal examination and USG, Volume of prostate 30\-60ml,International Prostate symptoms score(IPSS)1\-19, PSA less than 4ng/ml, Patient unwilling to sign the consent form.

Exclusion Criteria

  • Bladder stones , Stricture Urethra, Renal \& Hepatic Failure Malignancy, Patient unwilling to sign the consent form.

Outcomes

Primary Outcomes

Not specified

Similar Trials